WINDLAS — Windlas Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹18.71bn
- IN₹16.64bn
- IN₹7.60bn
- 80
- 18
- 65
- 57
Annual cashflow statement for Windlas Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 217 | 456 | 570 | 771 | 798 |
| Depreciation | |||||
| Non-Cash Items | 229 | -18.9 | -44.7 | -63.8 | -89.1 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -403 | -467 | -39.7 | 248 | -306 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 173 | 91.3 | 610 | 1,090 | 682 |
| Capital Expenditures | -58.5 | -148 | -709 | -377 | -522 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -144 | -1,398 | 568 | -544 | -219 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -202 | -1,546 | -141 | -921 | -741 |
| Financing Cash Flow Items | -26.4 | -92 | -19.2 | -11.1 | 0.44 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.76 | 1,301 | -437 | -153 | 10.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -21.5 | -154 | 31.2 | 16 | -48.6 |